{"id":232727,"date":"2026-04-08T23:32:00","date_gmt":"2026-04-09T03:32:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/04\/08\/yaosu-technology-secures-rmb-200m-in-financing-integrating-ai-organ-on-a-chip-into-new-drug-development-process\/"},"modified":"2026-04-09T01:05:29","modified_gmt":"2026-04-09T05:05:29","slug":"yaosu-technology-secures-rmb-200m-in-financing-integrating-ai-organ-on-a-chip-into-new-drug-development-process","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/04\/08\/yaosu-technology-secures-rmb-200m-in-financing-integrating-ai-organ-on-a-chip-into-new-drug-development-process\/","title":{"rendered":"Yaosu Technology Secures RMB 200M in Financing: Integrating “AI + Organ-on-a-Chip” into New Drug Development Process"},"content":{"rendered":"

Yaosu Technology Secures RMB 200M in Financing: Integrating “AI + Organ-on-a-Chip” into New Drug Development Process<\/a><\/p>\n

https:\/\/eu.36kr.com\/en\/p\/3758982738641670<\/a><\/p>\n

Publish Date: 2026-04-08 23:32:00<\/a><\/p>\n

Source Domain: eu.36kr.com<\/a><\/p>\n

Text | Hu Xiangyun<\/p>\n

Editor | Hai Ruojing<\/p>\n

The pharmaceutical industry is one step closer to “saying goodbye” to animal testing.<\/p>\n

Since the approval of the FDA Modernization Act 2.0 in 2022, the regulatory strategy of “replacing animal testing” has been ongoing. In mid-March this year, the FDA finally issued a statement, stating that it would start accepting non-animal data to support new drug reviews and encourage the use of new methodologies (NAMs) such as organoids\/organ-on-a-chip and AI toxicology models to gradually reduce pharmaceutical companies’ reliance on animal testing.<\/p>\n

\n

Image source: FDA official website<\/p>\n

With the deepening of policies, the voice of organoid\/organ-on-a-chip companies in the primary market has gradually increased. Just this year, at least five related companies have disclosed financing. For example, in early April, the AI for 3D Bioliogy platform company Yaosu Technology just announced the completion of a 200 million RMB Series A financing. This round of fundraising was exclusively led by China Life Equity, and old shareholders XtalPi, Yayi Capital, and Legend Capital increased their investments.<\/p>\n

Xie Xin, the founder and CEO of Yaosu Technology, explained that the new FDA draft shows that regulatory authorities are actively lowering the early use threshold of new methodologies such as organoids\/organ-on-a-chip. “This helps to accelerate the entry of new technologies into the real R & D process and complete data accumulation. In the future, our technology platform is also expected to directly enter the IND declaration system and become a standard tool in the new drug R & D process.”<\/p>\n

Previously, one of the major doubts about organoid\/organ-on-a-chip companies in the pharmaceutical industry was whether their data could be recognized by regulators and truly used in new drug approvals. Now, the new FDA draft has, to a certain extent, dispelled the industry’s concerns about regulatory uncertainty and also opened a key link for related companies…<\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Yaosu Technology Secures RMB 200M in Financing: Integrating “AI + Organ-on-a-Chip” into New Drug Development…<\/p>\n","protected":false},"author":1,"featured_media":232728,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/img.36krcdn.com\/hsossms\/20260409\/v2_54b83c114cfe4ec3b5defec6f0f50970@5930287@ai_oswg1019187oswg1053oswg495_img_png~tplv-1marlgjv7f-ai-v3:600:400:600:400:q70.jpg","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-232727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/232727"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=232727"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/232727\/revisions"}],"predecessor-version":[{"id":232729,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/232727\/revisions\/232729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/232728"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=232727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=232727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=232727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}